Apollomics Announces Settlement of Cayman Litigation GlobeNewswire November 19, 2025 FOSTER CITY, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — Apollomics Inc. (“Apollomics” or the “Company”) (Nasdaq: APLM) announced today entering into a settlement agreement (the “Settlement Agreement” or the “Agreement”) with TWVC Goldlink Partners Investment Limited and TWVC Panglin Group Investment Limited (together, “TWVC”), entities […]

(NASDAQ:DXCM),(NASDAQ:SNPS),(NYSE:KMX),(NYSE:FI), NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of DexCom, Inc. (NASDAQ:DXCM), Synopsys, Inc. (NASDAQ:SNPS), CarMax, Inc. (NYSE:KMX), and Fiserv, Inc. (NYSE:FI). Stockholders have until the deadlines below to petition

Bragar Eagel & Squire, P.C. Urges Stockholders of DexCom, Synopsys, CarMax, and Fiserv to Contact the Firm Regarding Their Rights GlobeNewswire November 19, 2025 NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of

https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western AllianceBancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public. So what: If you purchased Western Alliance Bancorporation securities you may

The outlook for the KLKB1 inhibitors market is increasingly positive, driven by growing recognition of the kallikrein-kinin pathway's pivotal role in inflammatory, cardiovascular, and rare disease mechanisms. Recent product approvals, such as TAKHZYRO, EKTERLY, KALBITOR, ORLADEYO, and DAWNZTERA, along with emerging therapies such as Lonvoguran ziclumeran (Intellia Therapeutics), Navenibart (Astria Therapeutics), RZ402 (Rezolute), and others,

Fidelity Investments CanadaULC today announced the November 2025 cash distributions for the Fidelity ETFs (“Fidelity ETFs”) and ETF Series of Fidelity mutual funds (“Fidelity Funds”) listed below. For Fidelity ETFs, unitholders of record as of November 26, 2025, will receive a per-unit cash distribution payable on November 28, 2025, as detailed in the table below:

NEW YORK, NY / ACCESS Newswire / November 19, 2025 / – SueWallSt: Class Action Filed Against aTyr Pharma, Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between November 7, 2024 and September 12, 2025. If you

(NYSE:SEMR), NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire

NEW YORK, NY / ACCESS Newswire / November 19, 2025 / – SueWallSt: Class Action Filed Against MoonLake Immunotherapeutics – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between March 10, 2024 and September 29, 2025. If you suffered

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Semrush Holdings, Inc. (NYSE: SEMR) GlobeNewswire November 19, 2025 NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a